Evaluating the impact of COVID-19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network
2021-01-01 Hulbert-Williams, N. J.; Leslie, M.; Hulbert-Williams, L.; Smith, E.; Howells, L.; Pinato, D. J.
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression
2021-01-01 Natoli, M.; Gallon, J.; Lu, H.; Amgheib, A.; Pinato, D. J.; Mauri, F. A.; Marafioti, T.; Akarca, A. U.; Ullmo, I.; Ip, J.; Aboagye, E. O.; Brown, R.; Karadimitris, A.; Ghaem-Maghami, S.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors
2020-01-01 Khaki, A. R.; Li, A.; Diamantopoulos, L. N.; Bilen, M. A.; Santos, V.; Esther, J.; Morales-Barrera, R.; Devitt, M.; Nelson, A.; Hoimes, C. J.; Shreck, E.; Assi, H.; Gartrell, B. A.; Sankin, A.; Rodriguez-Vida, A.; Lythgoe, M.; Pinato, D. J.; Drakaki, A.; Joshi, M.; Isaacsson Velho, P.; Hahn, N.; Liu, S.; Alonso Buznego, L.; Duran, I.; Moses, M.; Jain, J.; Murgic, J.; Baratam, P.; Barata, P.; Tripathi, A.; Zakharia, Y.; Galsky, M. D.; Sonpavde, G.; Yu, E. Y.; Shankaran, V.; Lyman, G. H.; Grivas, P.
Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
2020-01-01 Abu-Sbeih, H.; Faleck, D. M.; Ricciuti, B.; Mendelsohn, R. B.; Naqash, A. R.; Cohen, J. V.; Sellers, M. C.; Balaji, A.; Ben-Betzalel, G.; Hajir, I.; Zhang, J.; Awad, M. M.; Leonardi, G. C.; Johnson, D. B.; Pinato, D. J.; Owen, D. H.; Weiss, S. A.; Lamberti, G.; Lythgoe, M. P.; Manuzzi, L.; Arnold, C.; Qiao, W.; Naidoo, J.; Markel, G.; Powell, N.; Yeung, S. -C. J.; Sharon, E.; Dougan, M.; Wang, Y.
Programmed cell death ligands expression drives immune tolerogenesis across the diverse subtypes of neuroendocrine tumours
2020-01-01 Pinato, David J; Vallipuram, Anu; Evans, Joanne S; Wong, Clement; Zhang, Hua; Brown, Matthew; Dina, Roberto E; Trivedi, Pritesh; Akarca, Ayse U; Marafioti, Teresa; Mauri, Francesco A; Sharma, Rohini
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
2020-01-01 Pinato, D. J.; Kaseb, A.; Wang, Y.; Saeed, A.; Szafron, D.; Jun, T.; Dharmapuri, S.; Naqash, A. R.; Muzaffar, M.; Navaid, M.; Khan, U.; Lee, C.; Bulumulle, A.; Yu, B.; Paul, S.; Fessas, P.; Nimkar, N.; Bettinger, D.; Hildebrand, H.; Pressiani, T.; Abugabal, Y. I.; Personeni, N.; Huang, Y. -H.; Lozano-Kuehne, J.; Rimassa, L.; Ang, C.; Marron, T. U.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study
2020-01-01 Miller, N. J.; Khaki, A. R.; Diamantopoulos, L. N.; Bilen, M. A.; Santos, V.; Agarwal, N.; Morales-Barrera, R.; Devitt, M.; Nelson, A.; Hoimes, C. J.; Shreck, E.; Assi, H.; Gartrell, B. A.; Sankin, A.; Rodriguez-Vida, A.; Lythgoe, M.; Pinato, D. J.; Drakaki, A.; Joshi, M.; Isaacsson Velho, P.; Hahn, N.; Liu, S.; Alonso Buznego, L.; Duran, I.; Moses, M.; Jain, J.; Murgic, J.; Barata, P.; Tripathi, A.; Zakharia, Y.; Galsky, M. D.; Sonpavde, G.; Yu, E. Y.; Lyman, G. H.; Grivas, P.
Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated with Immune Checkpoint Inhibitor Therapy
2020-01-01 Pinato, D. J.; Urus, H.; Newsom-Davis, T.; Du Parcq, P.; Belessiotis, K.; Mapara, L.; Gupta, N.; Power, D.; Weir, J.; Wong, C. N.; Ratnakumaran, R. P.; Dominy, K.; Khorashad, J.; Bower, M.
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
2020-01-01 Sarker, D.; Plummer, R.; Meyer, T.; Sodergren, M. H.; Basu, B.; Chee, C. E.; Huang, K. -W.; Palmer, D. H.; Ma, Y. T.; Evans, T. R. J.; Spalding, D. R. C.; Pai, M.; Sharma, R.; Pinato, D. J.; Spicer, J.; Hunter, S.; Kwatra, V.; Nicholls, J. P.; Collin, D.; Nutbrown, R.; Glenny, H.; Fairbairn, S.; Reebye, V.; Voutila, J.; Dorman, S.; Andrikakou, P.; Lloyd, P.; Felstead, S.; Vasara, J.; Habib, R.; Wood, C.; Saetrom, P.; Huber, H. E.; Blakey, D. C.; Rossi, J. J.; Habib, N.
Immune-based therapies for hepatocellular carcinoma
2020-01-01 Pinato, D. J.; Guerra, N.; Fessas, P.; Murphy, R.; Mineo, T.; Mauri, F. A.; Mukherjee, S. K.; Thursz, M.; Wong, C. N.; Sharma, R.; Rimassa, L.
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
2020-01-01 Cortellini, A.; Tucci, M.; Adamo, V.; Stucci, L. S.; Russo, A.; Tanda, E. T.; Spagnolo, F.; Rastelli, F.; Bisonni, R.; Santini, D.; Russano, M.; Anesi, C.; Giusti, R.; Filetti, M.; Marchetti, P.; Botticelli, A.; Gelibter, A.; Occhipinti, M. A.; Marconcini, R.; Vitale, M. G.; Nicolardi, L.; Chiari, R.; Bareggi, C.; Nigro, O.; Tuzi, A.; De Tursi, M.; Petragnani, N.; Pala, L.; Bracarda, S.; Macrini, S.; Inno, A.; Zoratto, F.; Veltri, E.; DI Cocco, B.; Mallardo, D.; Vitale, M. G.; Pinato, D. J.; Porzio, G.; Ficorella, C.; Ascierto, P. A.
Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using 18F-Fluorothymidine PET
2020-01-01 Sharma, R.; Inglese, M.; Dubash, S.; Lu, H.; Pinato, D. J.; Sanghera, C.; Patel, N.; Chung, A.; Tait, P. D.; Mauri, F.; Crum, W. R.; Barwick, T. D.; Aboagye, E. O.
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
2020-01-01 Fessas, P.; Kaseb, A.; Wang, Y.; Saeed, A.; Szafron, D.; Jun, T.; Dharmapuri, S.; Rafeh Naqash, A.; Muzaffar, M.; Navaid, M.; Khan, U.; Lee, C.; Bulumulle, A.; Yu, B.; Paul, S.; Nimkar, N.; Bettinger, D.; Benevento, F.; Hildebrand, H.; Pressiani, T.; Abugabal, Y. I.; Personeni, N.; Huang, Y. -H.; Rimassa, L.; Ang, C.; Marron, T.; Pinato, D. J.
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
2020-01-01 Motedayen Aval, Leila; Pease, James E; Sharma, Rohini; Pinato, David J
Biliary tract cancers: Molecular heterogeneity and new treatment options
2020-01-01 Personeni, N.; Lleo, A.; Pressiani, T.; Colapietro, F.; Openshaw, M. R.; Stavraka, C.; Pouptsis, A.; Pinato, D. J.; Rimassa, L.
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms
2020-01-01 Fessas, P.; Possamai, L. A.; Clark, J.; Daniels, E.; Gudd, C.; Mullish, B. H.; Alexander, J. L.; Pinato, D. J.
Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients with Cancer - Reply
2020-01-01 Pinato, D. J.; Newsom-Davis, T.; Bower, M.
Management of Hepatocellular Cancer in the time of SARS-CoV-2
2020-01-01 Sharma, R.; Pinato, D. J.
Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: Adjunctive role of the albi grade
2020-01-01 Pinato, D. J.; Kaneko, T.; Saeed, A.; Pressiani, T.; Kaseb, A.; Wang, Y.; Szafron, D.; Jun, T.; Dharmapuri, S.; Naqash, A. R.; Muzaffar, M.; Navaid, M.; Lee, C. -J.; Bulumulle, A.; Yu, B.; Paul, S.; Nimkar, N.; Bettinger, D.; Hildebrand, H.; Abugabal, Y. I.; Ang, C.; Marron, T. U.; Khan, U.; Personeni, N.; Rimassa, L.; Huang, Y. -H.
Acceleration of interstitial lung disease induced by raltitrexed
2020-01-01 Howlett, S.; Aul, R.; Hill, M.; Pinato, D. J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluating the impact of COVID-19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network | 1-gen-2021 | Hulbert-Williams, N. J.; Leslie, M.; Hulbert-Williams, L.; Smith, E.; Howells, L.; Pinato, D. J. | |
| Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression | 1-gen-2021 | Natoli, M.; Gallon, J.; Lu, H.; Amgheib, A.; Pinato, D. J.; Mauri, F. A.; Marafioti, T.; Akarca, A. U.; Ullmo, I.; Ip, J.; Aboagye, E. O.; Brown, R.; Karadimitris, A.; Ghaem-Maghami, S. | |
| Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors | 1-gen-2020 | Khaki, A. R.; Li, A.; Diamantopoulos, L. N.; Bilen, M. A.; Santos, V.; Esther, J.; Morales-Barrera, R.; Devitt, M.; Nelson, A.; Hoimes, C. J.; Shreck, E.; Assi, H.; Gartrell, B. A.; Sankin, A.; Rodriguez-Vida, A.; Lythgoe, M.; Pinato, D. J.; Drakaki, A.; Joshi, M.; Isaacsson Velho, P.; Hahn, N.; Liu, S.; Alonso Buznego, L.; Duran, I.; Moses, M.; Jain, J.; Murgic, J.; Baratam, P.; Barata, P.; Tripathi, A.; Zakharia, Y.; Galsky, M. D.; Sonpavde, G.; Yu, E. Y.; Shankaran, V.; Lyman, G. H.; Grivas, P. | |
| Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease | 1-gen-2020 | Abu-Sbeih, H.; Faleck, D. M.; Ricciuti, B.; Mendelsohn, R. B.; Naqash, A. R.; Cohen, J. V.; Sellers, M. C.; Balaji, A.; Ben-Betzalel, G.; Hajir, I.; Zhang, J.; Awad, M. M.; Leonardi, G. C.; Johnson, D. B.; Pinato, D. J.; Owen, D. H.; Weiss, S. A.; Lamberti, G.; Lythgoe, M. P.; Manuzzi, L.; Arnold, C.; Qiao, W.; Naidoo, J.; Markel, G.; Powell, N.; Yeung, S. -C. J.; Sharon, E.; Dougan, M.; Wang, Y. | |
| Programmed cell death ligands expression drives immune tolerogenesis across the diverse subtypes of neuroendocrine tumours | 1-gen-2020 | Pinato, David J; Vallipuram, Anu; Evans, Joanne S; Wong, Clement; Zhang, Hua; Brown, Matthew; Dina, Roberto E; Trivedi, Pritesh; Akarca, Ayse U; Marafioti, Teresa; Mauri, Francesco A; Sharma, Rohini | |
| Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy | 1-gen-2020 | Pinato, D. J.; Kaseb, A.; Wang, Y.; Saeed, A.; Szafron, D.; Jun, T.; Dharmapuri, S.; Naqash, A. R.; Muzaffar, M.; Navaid, M.; Khan, U.; Lee, C.; Bulumulle, A.; Yu, B.; Paul, S.; Fessas, P.; Nimkar, N.; Bettinger, D.; Hildebrand, H.; Pressiani, T.; Abugabal, Y. I.; Personeni, N.; Huang, Y. -H.; Lozano-Kuehne, J.; Rimassa, L.; Ang, C.; Marron, T. U. | |
| Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study | 1-gen-2020 | Miller, N. J.; Khaki, A. R.; Diamantopoulos, L. N.; Bilen, M. A.; Santos, V.; Agarwal, N.; Morales-Barrera, R.; Devitt, M.; Nelson, A.; Hoimes, C. J.; Shreck, E.; Assi, H.; Gartrell, B. A.; Sankin, A.; Rodriguez-Vida, A.; Lythgoe, M.; Pinato, D. J.; Drakaki, A.; Joshi, M.; Isaacsson Velho, P.; Hahn, N.; Liu, S.; Alonso Buznego, L.; Duran, I.; Moses, M.; Jain, J.; Murgic, J.; Barata, P.; Tripathi, A.; Zakharia, Y.; Galsky, M. D.; Sonpavde, G.; Yu, E. Y.; Lyman, G. H.; Grivas, P. | |
| Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated with Immune Checkpoint Inhibitor Therapy | 1-gen-2020 | Pinato, D. J.; Urus, H.; Newsom-Davis, T.; Du Parcq, P.; Belessiotis, K.; Mapara, L.; Gupta, N.; Power, D.; Weir, J.; Wong, C. N.; Ratnakumaran, R. P.; Dominy, K.; Khorashad, J.; Bower, M. | |
| MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | 1-gen-2020 | Sarker, D.; Plummer, R.; Meyer, T.; Sodergren, M. H.; Basu, B.; Chee, C. E.; Huang, K. -W.; Palmer, D. H.; Ma, Y. T.; Evans, T. R. J.; Spalding, D. R. C.; Pai, M.; Sharma, R.; Pinato, D. J.; Spicer, J.; Hunter, S.; Kwatra, V.; Nicholls, J. P.; Collin, D.; Nutbrown, R.; Glenny, H.; Fairbairn, S.; Reebye, V.; Voutila, J.; Dorman, S.; Andrikakou, P.; Lloyd, P.; Felstead, S.; Vasara, J.; Habib, R.; Wood, C.; Saetrom, P.; Huber, H. E.; Blakey, D. C.; Rossi, J. J.; Habib, N. | |
| Immune-based therapies for hepatocellular carcinoma | 1-gen-2020 | Pinato, D. J.; Guerra, N.; Fessas, P.; Murphy, R.; Mineo, T.; Mauri, F. A.; Mukherjee, S. K.; Thursz, M.; Wong, C. N.; Sharma, R.; Rimassa, L. | |
| Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice | 1-gen-2020 | Cortellini, A.; Tucci, M.; Adamo, V.; Stucci, L. S.; Russo, A.; Tanda, E. T.; Spagnolo, F.; Rastelli, F.; Bisonni, R.; Santini, D.; Russano, M.; Anesi, C.; Giusti, R.; Filetti, M.; Marchetti, P.; Botticelli, A.; Gelibter, A.; Occhipinti, M. A.; Marconcini, R.; Vitale, M. G.; Nicolardi, L.; Chiari, R.; Bareggi, C.; Nigro, O.; Tuzi, A.; De Tursi, M.; Petragnani, N.; Pala, L.; Bracarda, S.; Macrini, S.; Inno, A.; Zoratto, F.; Veltri, E.; DI Cocco, B.; Mallardo, D.; Vitale, M. G.; Pinato, D. J.; Porzio, G.; Ficorella, C.; Ascierto, P. A. | |
| Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using 18F-Fluorothymidine PET | 1-gen-2020 | Sharma, R.; Inglese, M.; Dubash, S.; Lu, H.; Pinato, D. J.; Sanghera, C.; Patel, N.; Chung, A.; Tait, P. D.; Mauri, F.; Crum, W. R.; Barwick, T. D.; Aboagye, E. O. | |
| Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study | 1-gen-2020 | Fessas, P.; Kaseb, A.; Wang, Y.; Saeed, A.; Szafron, D.; Jun, T.; Dharmapuri, S.; Rafeh Naqash, A.; Muzaffar, M.; Navaid, M.; Khan, U.; Lee, C.; Bulumulle, A.; Yu, B.; Paul, S.; Nimkar, N.; Bettinger, D.; Benevento, F.; Hildebrand, H.; Pressiani, T.; Abugabal, Y. I.; Personeni, N.; Huang, Y. -H.; Rimassa, L.; Ang, C.; Marron, T.; Pinato, D. J. | |
| Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy | 1-gen-2020 | Motedayen Aval, Leila; Pease, James E; Sharma, Rohini; Pinato, David J | |
| Biliary tract cancers: Molecular heterogeneity and new treatment options | 1-gen-2020 | Personeni, N.; Lleo, A.; Pressiani, T.; Colapietro, F.; Openshaw, M. R.; Stavraka, C.; Pouptsis, A.; Pinato, D. J.; Rimassa, L. | |
| Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms | 1-gen-2020 | Fessas, P.; Possamai, L. A.; Clark, J.; Daniels, E.; Gudd, C.; Mullish, B. H.; Alexander, J. L.; Pinato, D. J. | |
| Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients with Cancer - Reply | 1-gen-2020 | Pinato, D. J.; Newsom-Davis, T.; Bower, M. | |
| Management of Hepatocellular Cancer in the time of SARS-CoV-2 | 1-gen-2020 | Sharma, R.; Pinato, D. J. | |
| Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: Adjunctive role of the albi grade | 1-gen-2020 | Pinato, D. J.; Kaneko, T.; Saeed, A.; Pressiani, T.; Kaseb, A.; Wang, Y.; Szafron, D.; Jun, T.; Dharmapuri, S.; Naqash, A. R.; Muzaffar, M.; Navaid, M.; Lee, C. -J.; Bulumulle, A.; Yu, B.; Paul, S.; Nimkar, N.; Bettinger, D.; Hildebrand, H.; Abugabal, Y. I.; Ang, C.; Marron, T. U.; Khan, U.; Personeni, N.; Rimassa, L.; Huang, Y. -H. | |
| Acceleration of interstitial lung disease induced by raltitrexed | 1-gen-2020 | Howlett, S.; Aul, R.; Hill, M.; Pinato, D. J. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista36181
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa64
- 2020 - 20269919
- 2010 - 201913042
- 2000 - 20097282
- 1990 - 19994152
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B771
- JOURNAL OF HIGH ENERGY PHYSICS499
- PHYSICAL REVIEW LETTERS295
- THE EUROPEAN PHYSICAL JOURNAL. C,...284
- PHYSICAL REVIEW D234
- JOURNAL OF HIGH ENERGY PHYSICS183
- PLOS ONE181
- BLOOD169
- INTERNATIONAL JOURNAL OF MOLECULA...164
- NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
- Humans1437
- Female757
- Male607
- Middle Aged459
- Adult415
- Aged406
- COVID-19344
- Italy298
- Animals217
- Treatment Outcome196
Lingua
- eng24780
- ita5291
- fre259
- spa169
- ger58
- rus29
- und26
- por17
- lat15
- grc6
Accesso al fulltext
- no fulltext21435
- reserved7318
- open4977
- restricted2336
- partially open90
- embargoed17
- mixed9